ClinicalTrials.Veeva

Menu

Effect of Galactose Ingestion on Postprandial Lipemia

U

University of Bath

Status

Completed

Conditions

Lipemia
Cardiovascular Risk Factor

Treatments

Dietary Supplement: Galactose
Dietary Supplement: Glucose

Study type

Interventional

Funder types

Other

Identifiers

NCT03439878
MSES 16/17-011

Details and patient eligibility

About

This study aims to assess the postprandial triglyceride response to the ingestion of a high-fat meal with co-ingestion of either galactose, or glucose.

Enrollment

10 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male
  • 18 to 35 years old
  • Body mass index <30 kg/m2

Exclusion criteria

  • Female
  • Body mass index >29.9 kg/m2
  • Any history of metabolic disease
  • Allergies or intolerances to milk and/or cream

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

10 participants in 2 patient groups

Galactose
Experimental group
Description:
Ingestion of 0.75 g/kg body mass of d-galactose monohydrate co-ingested with cream to provide 1 g/kg body mass of fat.
Treatment:
Dietary Supplement: Galactose
Glucose
Active Comparator group
Description:
Ingestion of 0.75 g/kg body mass of dextrose monohydrate co-ingested with cream to provide 1 g/kg body mass of fat.
Treatment:
Dietary Supplement: Glucose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems